Piscataway, NJ, United States of America

William R Moyle

USPTO Granted Patents = 12 (Patent Applications = 1)

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 188(Granted Patents)

Company Filing History:

University of Medicine and Dentistry of New Jersey

patents

2 out of 1,579

Washington University

5. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8603974 - Salmon follitropin hormone analogs (2013-12-10),

2. 8530190 - Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use (2013-09-10),

3. 7741106 - Sensors for biomolecular detection and cell classification (2010-06-22),

4. 7384781 - Sensors for biomolecular detection and cell classification (2008-06-10),

5. 7001597 - Methods for altering fertility (2006-02-21),

6. 6486303 - Method for making hormone heterodimers (2002-11-26),

7. 6242580 - Single-chain forms of the glycoprotein hormone quartet (2001-06-05),

8. 6238890 - Single chain forms of the glycoprotein hormone quartet (2001-05-29),

9. 5508261 - Analogs of glycoprotein hormones having altered receptor binding (1996-04-16),

10. 5284778 - Sensitive bioassay using monoclonal antibodies which bind to (1994-02-08),

11. 4792528 - Methods for obtaining monoclonal antibodies useful in enhanced (1988-12-20),

12. 4514505 - Monoclonal antibody mixtures and use thereof for enhanced sensitivity (1985-04-30),

Title: The Innovations of William R Moyle

Introduction

William R Moyle is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of glycoprotein hormone analogs, holding a total of 12 patents. His work has advanced the understanding and application of hormone analogs in various scientific and medical contexts.

Latest Patents

One of his latest patents focuses on salmon follitropin hormone analogs. This invention relates to glycoprotein hormone analogs and their uses as agonists, antagonists, targeting vectors, and immunogens. The invention describes a method for stabilizing a heterodimer that allows for the preparation of functional glycoprotein hormone analogs. The analogs consist of at least one alpha subunit polypeptide and at least one beta subunit polypeptide, with the seatbelt region of the beta subunit linked to the alpha subunit. Another significant patent involves disulfide crosslinked glycoprotein hormone analogs, detailing their preparation and use, along with corresponding DNA sequences and host cells, as well as pharmaceutical compositions.

Career Highlights

Throughout his career, William R Moyle has worked with prestigious institutions, including Columbia University. His innovative research has led to advancements in the field of biochemistry and hormone therapy.

Collaborations

Moyle has collaborated with notable individuals such as Robert E Canfield and Irving Boime. These partnerships have contributed to the success and impact of his inventions.

Conclusion

William R Moyle's contributions to the field of glycoprotein hormone analogs demonstrate his innovative spirit and dedication to scientific advancement. His patents continue to influence research and applications in hormone therapy and related fields.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.